- Disease: Post-COVID-19
- Study type: Randomised Clinical Trial
- Study type descriptors: Interventional
- Study aim: To evaluate the efficiency and safety of immunoadsorption for the treatment of post-COVID syndrome. To investigate the efficacy of immunoadsorption compared to sham treatment for the management of post-COVID syndrome
- Number of participants enrolled: 40
- Study enrolling from to
- Study includes follow-up for 2 weeks
Study Data
- Adults
- Elderly
- General population
- SARS-CoV-2
- Post-COVID-19
- Non pharmacological intervention
- Immunoadsorption
External Links
Other information
Funders:
- University Medical Center Mainz
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to